11 min listen
NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.
FromNEJM Interviews
NEJM Interview: Dr. Peter Marks on the FDA’s experience with emergency use authorizations during the Covid-19 pandemic.
FromNEJM Interviews
ratings:
Length:
6 minutes
Released:
Mar 29, 2023
Format:
Podcast episode
Description
Dr. Peter Marks is the director of the FDA Center for Biologics Evaluation and Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P.W. Marks, H.D. Marston, and L.R. Baden. End of a Declared Public Health Emergency — Implications for U.S. Emergency Use Authorizations. N Engl J Med 2023;388:1153-1155.
Released:
Mar 29, 2023
Format:
Podcast episode
Titles in the series (100)
NEJM Interview: Cynthia Jackevicius on generic drugs and health care costs. by NEJM Interviews